Cargando…

Cerebral Iron Deposition in Neurodegeneration

Disruption of cerebral iron regulation appears to have a role in aging and in the pathogenesis of various neurodegenerative disorders. Possible unfavorable impacts of iron accumulation include reactive oxygen species generation, induction of ferroptosis, and acceleration of inflammatory changes. Who...

Descripción completa

Detalles Bibliográficos
Autores principales: Dusek, Petr, Hofer, Tim, Alexander, Jan, Roos, Per M., Aaseth, Jan O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138489/
https://www.ncbi.nlm.nih.gov/pubmed/35625641
http://dx.doi.org/10.3390/biom12050714
_version_ 1784714634966597632
author Dusek, Petr
Hofer, Tim
Alexander, Jan
Roos, Per M.
Aaseth, Jan O.
author_facet Dusek, Petr
Hofer, Tim
Alexander, Jan
Roos, Per M.
Aaseth, Jan O.
author_sort Dusek, Petr
collection PubMed
description Disruption of cerebral iron regulation appears to have a role in aging and in the pathogenesis of various neurodegenerative disorders. Possible unfavorable impacts of iron accumulation include reactive oxygen species generation, induction of ferroptosis, and acceleration of inflammatory changes. Whole-brain iron-sensitive magnetic resonance imaging (MRI) techniques allow the examination of macroscopic patterns of brain iron deposits in vivo, while modern analytical methods ex vivo enable the determination of metal-specific content inside individual cell-types, sometimes also within specific cellular compartments. The present review summarizes the whole brain, cellular, and subcellular patterns of iron accumulation in neurodegenerative diseases of genetic and sporadic origin. We also provide an update on mechanisms, biomarkers, and effects of brain iron accumulation in these disorders, focusing on recent publications. In Parkinson’s disease, Friedreich’s disease, and several disorders within the neurodegeneration with brain iron accumulation group, there is a focal siderosis, typically in regions with the most pronounced neuropathological changes. The second group of disorders including multiple sclerosis, Alzheimer’s disease, and amyotrophic lateral sclerosis shows iron accumulation in the globus pallidus, caudate, and putamen, and in specific cortical regions. Yet, other disorders such as aceruloplasminemia, neuroferritinopathy, or Wilson disease manifest with diffuse iron accumulation in the deep gray matter in a pattern comparable to or even more extensive than that observed during normal aging. On the microscopic level, brain iron deposits are present mostly in dystrophic microglia variably accompanied by iron-laden macrophages and in astrocytes, implicating a role of inflammatory changes and blood–brain barrier disturbance in iron accumulation. Options and potential benefits of iron reducing strategies in neurodegeneration are discussed. Future research investigating whether genetic predispositions play a role in brain Fe accumulation is necessary. If confirmed, the prevention of further brain Fe uptake in individuals at risk may be key for preventing neurodegenerative disorders.
format Online
Article
Text
id pubmed-9138489
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91384892022-05-28 Cerebral Iron Deposition in Neurodegeneration Dusek, Petr Hofer, Tim Alexander, Jan Roos, Per M. Aaseth, Jan O. Biomolecules Review Disruption of cerebral iron regulation appears to have a role in aging and in the pathogenesis of various neurodegenerative disorders. Possible unfavorable impacts of iron accumulation include reactive oxygen species generation, induction of ferroptosis, and acceleration of inflammatory changes. Whole-brain iron-sensitive magnetic resonance imaging (MRI) techniques allow the examination of macroscopic patterns of brain iron deposits in vivo, while modern analytical methods ex vivo enable the determination of metal-specific content inside individual cell-types, sometimes also within specific cellular compartments. The present review summarizes the whole brain, cellular, and subcellular patterns of iron accumulation in neurodegenerative diseases of genetic and sporadic origin. We also provide an update on mechanisms, biomarkers, and effects of brain iron accumulation in these disorders, focusing on recent publications. In Parkinson’s disease, Friedreich’s disease, and several disorders within the neurodegeneration with brain iron accumulation group, there is a focal siderosis, typically in regions with the most pronounced neuropathological changes. The second group of disorders including multiple sclerosis, Alzheimer’s disease, and amyotrophic lateral sclerosis shows iron accumulation in the globus pallidus, caudate, and putamen, and in specific cortical regions. Yet, other disorders such as aceruloplasminemia, neuroferritinopathy, or Wilson disease manifest with diffuse iron accumulation in the deep gray matter in a pattern comparable to or even more extensive than that observed during normal aging. On the microscopic level, brain iron deposits are present mostly in dystrophic microglia variably accompanied by iron-laden macrophages and in astrocytes, implicating a role of inflammatory changes and blood–brain barrier disturbance in iron accumulation. Options and potential benefits of iron reducing strategies in neurodegeneration are discussed. Future research investigating whether genetic predispositions play a role in brain Fe accumulation is necessary. If confirmed, the prevention of further brain Fe uptake in individuals at risk may be key for preventing neurodegenerative disorders. MDPI 2022-05-17 /pmc/articles/PMC9138489/ /pubmed/35625641 http://dx.doi.org/10.3390/biom12050714 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Dusek, Petr
Hofer, Tim
Alexander, Jan
Roos, Per M.
Aaseth, Jan O.
Cerebral Iron Deposition in Neurodegeneration
title Cerebral Iron Deposition in Neurodegeneration
title_full Cerebral Iron Deposition in Neurodegeneration
title_fullStr Cerebral Iron Deposition in Neurodegeneration
title_full_unstemmed Cerebral Iron Deposition in Neurodegeneration
title_short Cerebral Iron Deposition in Neurodegeneration
title_sort cerebral iron deposition in neurodegeneration
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138489/
https://www.ncbi.nlm.nih.gov/pubmed/35625641
http://dx.doi.org/10.3390/biom12050714
work_keys_str_mv AT dusekpetr cerebralirondepositioninneurodegeneration
AT hofertim cerebralirondepositioninneurodegeneration
AT alexanderjan cerebralirondepositioninneurodegeneration
AT roosperm cerebralirondepositioninneurodegeneration
AT aasethjano cerebralirondepositioninneurodegeneration